Emerging growth, development-stage biopharmaceutical company Celsus Therapeutics announced its recruitment of biopharmaceutical industry veteran Allan Shaw to its Board of Directors. Shaw will sit in the position of Chairman of the Audit Committee.
“We are pleased to have Allan join our Board of Directors and serve on the Audit Committee,” stated Executive Chairman of the Board of Directors of Celsus Therapeutics, Mark Cohen. “With over twenty-five years of demonstrated success in financial management, corporate leadership and international operations, Allan’s experience further strengthens our Board and we look forward to utilizing his unique expertise to aid in the next stage of development of Celsus Therapeutics.”
“I am excited to join the Celsus Board and to have the opportunity to help develop the Company’s novel anti-inflammatory drug candidates. I look forward to working with the Board to guide the Company and shape its future,” commented Shaw.
Currently overseeing Alvarez & Marsal’s biopharmaceutical consulting practice, Shaw served as a member of the Board of Directors for the Central New York Biotech Accelerator, formerly known as Central New York-Biotech Research Center. Previously, he held the position of Chief Financial Officer and executive management board member of Serono International S.A., currently the largest European global biotechnology company. In addition he was the founder and Senior Managing Director of Shaw Strategic Capital LLC, an international financial advisory firm, focused specifically on financial counseling on issues such as mergers and acquisitions, general corporate finance, capital structuring, licensing, and capital markets. His clients have included a biopharmaceutical licensing / developmental group and an international investment bank, of which he acted as a strategic adviser.
Additionally, Shaw has served as a Board member and Chief Financial Officer for NewLead Holdings LTD (NEWL), as well as an independent board member of Navios Maritime Holdings Inc.’s, serving as the designated financial expert in the position of Chairman for Navios’ Audit and Compensation Committees. He has also contributed to a number of corporate governance books and is a member of the American Institute of Certified Public Accountants, New York Society of Certified Public Accountants, and Corporate Directors Group.
Shaw earned a Bachelor of Science from the State University of New York (Oswego College), and is currently a certified public accountant in the State of New York.
To learn more, please visit www.celsustx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
